<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02762656</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-16-2972-VS-CTIL</org_study_id>
    <nct_id>NCT02762656</nct_id>
  </id_info>
  <brief_title>The Effect of Perioperative Lidocaine Intravenous Infusion on Postoperative Recovery After Spine Surgery.</brief_title>
  <official_title>The Effect of Perioperative Lidocaine Intravenous Infusion on Postoperative Recovery After Spine Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of perioperative Lidocaine
      intravenous infusion in reducing postoperative pain for spine surgery patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study design: this study used a prospective, randomized, double-blinded, and
      placebo-controlled clinical trial.

      Sixty patients scheduled for a spine surgery will be randomly assigned to two groups.
      Lidocaine group will receive an intravenous bolus injection of lidocaine 1.5 mg/kg before
      intubation, followed by 2 mg/kg/h continuous infusion during the operation. Placebo group
      will receive the same dosage of saline at the same time. Analgesic requirement will be
      monitored using patient-controlled Analgesia (PCA protocol: demand dose is 2 mg of morphine,
      lockout 5 min, maximum dose 15 mg per hour). Forty-eight hours after surgery, we will check
      the morphine consumption in two groups. Quality of recovery after surgery will be assessed
      using Q0R15 questionnaire.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>24 hours postop</time_frame>
    <description>Quality of recovery after surgery will be assessed using Q0R15 questionnaire and analgesic requirement will be monitored using PCA</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Spinal Diseases</condition>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive Lidocaine drip during spine surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive placebo during spine surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>Lidocaine drip during surgery</description>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  spine surgery with general anesthesia

        Exclusion Criteria:

          -  lidocaine allergy

          -  hepatic disease

          -  dementia or cognitive decline
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Haim Berkenstadt, MD</last_name>
    <phone>03-5302754</phone>
    <phone_ext>+972</phone_ext>
    <email>Haim.Berkenstadt@sheba.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vladimir Solovyev, MD</last_name>
    <phone>054-6800749</phone>
    <phone_ext>+972</phone_ext>
    <email>gaster1313@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>5262100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/24216403</url>
    <description>Intraoperative systemic infusion of lidocaine reduces postoperative pain after lumbar surgery: a double-blinded, randomized, placebo-controlled clinical trial.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/25785316</url>
    <description>Intravenous lidocaine for effective pain relief after a laparoscopic colectomy: a prospective, randomized, double-blind, placebo-controlled study.</description>
  </link>
  <link>
    <url>http://www.cochrane.org/CD009642/ANAESTH_intravenous-infusion-lidocaine-starting-time-surgery-reduction-pain-and-improvement-recovery-after</url>
    <description>Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery.</description>
  </link>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2016</study_first_submitted>
  <study_first_submitted_qc>May 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2016</study_first_posted>
  <last_update_submitted>May 3, 2016</last_update_submitted>
  <last_update_submitted_qc>May 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

